Condition: Atopic Dermatitis · Sponsor: Bambusa Therapeutics
This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
This description comes directly from the study's public registry record.
Lisa Li · +1 617-848-6188 · Lisa.Li@bambusatx.com
Always discuss trial participation with your own doctor first.
| First OC Dermatology | Irvine, California, United States | Not Yet Recruiting |
| OptiSkin Medical | New York, New York, United States | Recruiting |
| Equity Medical, LLC | The Bronx, New York, United States | Recruiting |
| Fremantle Dermatology | Fremantle, Western Australia, Australia | Not Yet Recruiting |
| Linear Clinical Research | Perth, Western Australia, Australia | Active Not Recruiting |
| Optimal Clinical Trials Central Auckland | Grafton, Auckland, New Zealand | Recruiting |
| Aotearoa Clinical Trials | Otahuhu, Auckland, New Zealand | Withdrawn |
| Pacific Clinical Research Network (PCRN) - Auckland | Takapuna, Auckland, New Zealand | Recruiting |
| Optimal Clinical Trials Ltd - Christchurch | Christchurch, Christchurch, New Zealand | Recruiting |
| Pacific Clinical Research Network (PCRN) Wellington | Upper Hutt, New Zealand | Recruiting |
| Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi | Lodz, Poland | Not Yet Recruiting |
| Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie | Rzeszów, Poland | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06808477